Evogene Stock Jumps 22% on $20M Financing Round for Microbiome Therapeutics – MarketWatch

December 21, 2022 by No Comments

By Sabela Ojea


Shares of Evogene Ltd. on Wednesday jumped about 22% after the data analysis biotech company said that its subsidiary Biomica Ltd. raised $20 million.

At 13:10 E.T., shares were up 22% at 78 cents. For the year, shares are down about 56%.

The Israel-based company said that Biomica is using funds, secured through a financing round, to advance its pipeline of microbiome-based therapeutics.

Microbiomes are the network of bacteria, fungi, viruses and other microorganisms that live inside the human body that affect the immune system.

The financing round was mainly led by the Chinese private equity fund Shanghai Healthcare Capital, Evogene added.


Write to Sabela Ojea at [email protected]; @sabelaojeaguix


Source: https://news.google.com/__i/rss/rd/articles/CBMieGh0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9zdG9yeS9ldm9nZW5lLXN0b2NrLWp1bXBzLTIyLW9uLTIwbS1maW5hbmNpbmctcm91bmQtZm9yLW1pY3JvYmlvbWUtdGhlcmFwZXV0aWNzLTI3MTY3MTY0NjgzMdIBfGh0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9hbXAvc3RvcnkvZXZvZ2VuZS1zdG9jay1qdW1wcy0yMi1vbi0yMG0tZmluYW5jaW5nLXJvdW5kLWZvci1taWNyb2Jpb21lLXRoZXJhcGV1dGljcy0yNzE2NzE2NDY4MzE?oc=5

Tags:

Leave a Comment

Your email address will not be published. Required fields are marked *